Pharma-Bio Serv (PBSV) Expected to Announce Earnings on Wednesday

Pharma-Bio Serv (OTCMKTS:PBSV) is anticipated to post its results before the market opens on Wednesday, February 4th. Analysts expect Pharma-Bio Serv to post earnings of $0.03 per share for the quarter.

Pharma-Bio Serv Trading Up 17.6%

Shares of PBSV opened at $0.54 on Wednesday. The firm has a market capitalization of $12.49 million, a P/E ratio of -54.45 and a beta of 0.73. Pharma-Bio Serv has a twelve month low of $0.35 and a twelve month high of $1.36. The firm’s 50-day moving average is $0.55 and its two-hundred day moving average is $0.58.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.